|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN THE EFFECTIVE BENEFICIARIES OF THE SHARES Filed under Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||
|
Table II – Beneficial ownership derivative securities (for exampleputs, calls, warrants, options, convertible securities)
(for exampleputs, calls, warrants, options, convertible securities)
|
1. Title of derivative title |
2. Conversion or exercise price of the derivative security |
3. Transaction date (month/day/year) |
3A. Deemed execution date, if applicable (month/day/year) |
4. Transaction code |
5. Number of derivative securities acquired (A) or sold (D) |
6. Exercise date and expiry date |
7. Title and amount of the securities underlying the derivative securities |
8. Price of derivative securities |
9. Number of derivative securities beneficially owned as a result of reported transactions |
10. Form of ownership of derivative securities: direct (D) or indirect (I) |
11. Nature of Indirect Beneficial Ownership |
|
Coded |
V |
(A) |
(D) |
Exercise date |
Expiration date |
Title |
Amount or number of shares |
Reporting owners
| Name/address of declaring owner | Relationships | |||
|
Director |
10% Owner |
Officer |
Other |
|
|
PHILLIPS JR CHARLES E NEW YORK, NY10013 |
Signatures
|
/s/ Melissa Curtin, lawyer in fact |
2022-07-12 |
| **Signature of declaring person |
Date |
Explanation of answers:
|
If the form is completed by several declarants, see |
|
| Section 5(b)(v). |
(**) Intentional misrepresentation or omission of facts are federal criminal offenses. See |
| 18 USC 1001 and 15 USC 78ff(a). |
(1) |
| Each deferred share unit represents a right to receive one Class A common share of the Corporation. |
(2) |
| The Reporting Person has elected, pursuant to the Issuer’s Directors’ Deferred Compensation Plan, to receive Deferred Share Units in lieu of cash honorarium for service on the Issuer’s Board of Directors. The DSU price shown here represents the closing price of the issuer’s Class A common stock on July 8, 2022, which price was used to calculate the number of DSUs issued to the Declarant. |
(3) |
Deferred share units will be settled in cash or Class A common stock, at the option of the issuer, within 45 days of the first occurrence of (i) separation from service; (ii) a change of control; (iii) death; or (iv) disability. Deferred share units issued in lieu of a cash provision vest 100% on the grant date. Note: Submit three copies of this form, one of which must be manually signed. If space is insufficient, See
Instruction 6 for the procedure. Potential individuals who need to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Disclaimer Oscar Health Inc. published this content on July 12, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unmodified, onJuly 12, 2022 8:23:06 PM UTC
.
|
|
|
|
|
|
Analyst Recommendations for OSCAR HEALTH, INC.
|
|
70.8%
|
|
||||
|
||||
Oscar Health, Inc. Technical Analysis Chart | MarketScreener
| Short term | Middle term | ||
| Long term | Tendencies | Neutral | Bearish |
Bearish
|
Please enable JavaScript in your browser settings to use dynamic graphics.  Sale |
|
| To buy | Medium consensus |
| HOLD | Number of analysts |
| 6 | Last closing price |
| $4.64 | Average target price |
| $8.42 | Average Spread / Target |
Please enable JavaScript in your browser settings to use dynamic graphics.
Comments are closed.